These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27881938)

  • 1. Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?
    Lesiak A; Bednarski I; Pałczyńska M; Kumiszcza E; Kraska-Gacka M; Woźniacka A; Narbutt J
    Postepy Dermatol Alergol; 2016 Oct; 33(5):336-339. PubMed ID: 27881938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
    Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
    Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis.
    Kim TH; Kim JS; Kwon JE; Park B; Lee ES
    Ann Dermatol; 2022 Feb; 34(1):7-13. PubMed ID: 35221589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of lipocalin 2 in palmoplantar pustular psoriasis.
    Wolk K; Frambach Y; Jacobi A; Wilsmann-Theis D; Phillipp S; Witte-Händel E; Wenzel J; Mössner R; Sabat R
    J Dermatol Sci; 2018 Apr; 90(1):68-74. PubMed ID: 29395573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DiGeorge syndrome presenting with palmoplantar pustules: Comparative analysis of serum IL-22, NETs and IL-8 with usual palmoplantar pustulosis.
    Ogura Y; Kondo S; Suzuki T; Otsuka M; Inuzuka M; Honda T; Tokura Y
    J Dermatol; 2024 May; 51(5):731-734. PubMed ID: 38111339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
    Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
    Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders.
    Liang Y; Xing X; Beamer MA; Swindell WR; Sarkar MK; Roberts LW; Voorhees JJ; Kahlenberg JM; Harms PW; Johnston A; Gudjonsson JE
    J Allergy Clin Immunol; 2017 Apr; 139(4):1217-1227. PubMed ID: 27884600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.
    Pinter A; Wilsmann-Theis D; Peitsch WK; Mössner R
    J Dermatol; 2019 May; 46(5):426-430. PubMed ID: 30786053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
    Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.
    Terui T; Kobayashi S; Okubo Y; Murakami M; Hirose K; Kubo H
    JAMA Dermatol; 2018 Mar; 154(3):309-316. PubMed ID: 29417135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin.
    Michaëlsson G; Gerdén B; Ottosson M; Parra A; Sjöberg O; Hjelmquist G; Lööf L
    Br J Dermatol; 1993 Dec; 129(6):667-73. PubMed ID: 8286249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet.
    Michaëlsson G; Kristjánsson G; Pihl Lundin I; Hagforsen E
    Br J Dermatol; 2007 Apr; 156(4):659-66. PubMed ID: 17263812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis.
    Yilmaz SB; Cicek N; Coskun M; Yegin O; Alpsoy E
    Arch Dermatol Res; 2012 Aug; 304(6):465-9. PubMed ID: 22426986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris.
    Bissonnette R; Suárez-Fariñas M; Li X; Bonifacio KM; Brodmerkel C; Fuentes-Duculan J; Krueger JG
    PLoS One; 2016; 11(5):e0155215. PubMed ID: 27152848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway.
    Bissonnette R; Fuentes-Duculan J; Mashiko S; Li X; Bonifacio KM; Cueto I; Suárez-Fariñas M; Maari C; Bolduc C; Nigen S; Sarfati M; Krueger JG
    J Dermatol Sci; 2017 Jan; 85(1):20-26. PubMed ID: 27743912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study.
    Avallone G; Maronese CA; Murgia G; Carrera CG; Mastorino L; Roccuzzo G; Dapavo P; Alberti-Violetti S; Quaglino P; Ribero S; Marzano AV
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous neutralizing anti-IL-1 alpha autoantibodies in inflammatory skin diseases: possible natural inhibitor for over expressed epidermal IL-1.
    Mizutani H; Ohmoto Y; Kupper TS; Shimizu M
    J Dermatol Sci; 1998 May; 20(1):63-71. PubMed ID: 10342749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study.
    Mrowietz U; Burden AD; Pinter A; Reich K; Schäkel K; Baum P; Datsenko Y; Deng H; Padula SJ; Thoma C; Bissonnette R
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):571-585. PubMed ID: 33661508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.